Business Recorder

PSO & Oman Trading discuss provision of additional oil cargoes

Pakistan, China propose five-point initiative for Gulf, Middle East stability PSO & Oman Trading discuss provision of ...

Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting

One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...
BroadwayWorld

Princeton Symphony Orchestra Names Tomás García as New Assistant Conductor

The Princeton Symphony Orchestra announced the appointment of Tomás García as its Georg and Joyce Albers-Schonberg Assistant ...
Detroit Free Press

Protagonist Therapeutics Announces U.S. FDA Approval of ICOTYDE(TM) (icotrokinra) for the Treatment of Moderate to Severe Plaque Psoriasis

ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...